Advisor Group’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
FAM
WRF
CCM
CS
CC
BG
GS
Advisor Group's CDNA Position: Q4 2019 in Review
Advisor Group reduced its CareDx (CDNA) stake by 49% in Q4 2019, selling an estimated $11.9K and leaving 542 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #4292.
Advisor Group first reported a position in CDNA in Q4 2017 and has held it in 9 quarters since. The position peaked at $690K in Q1 2019. 159 funds tracked by Wall St. Rank hold CDNA as of Q4 2019.
- Advisor Group held 542 shares of CareDx worth $11K as of Q4 2019.
- Advisor Group sold 517 CareDx shares in Q4 2019, an estimated $11.9K.
- CareDx made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #4292 holding.
- Advisor Group first reported a position in CareDx in Q4 2017 and has held it in 9 quarters since.
- Advisor Group's CareDx position peaked at $690K in Q1 2019.
- 159 funds tracked by Wall St. Rank held CareDx as of Q4 2019.
Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.